Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Differentiation into neural cell types describes the developmental process by which embryonic stem cells, neural stem cells, or neural crest cells commit to and become neurons, astrocytes, or oligodendrocytes, among other neural lineages[2][1][4]. This process is regulated by a network of signaling pathways (such as Wnt/β-catenin, Notch, bone morphogenetic protein (BMP), fibroblast growth factor (FGF), Sonic hedgehog (Shh), retinoic acid, and others), which control the expression of crucial transcription factors (including SOX family, NEUROD1, PAX genes, among others) that govern cell fate[2][1][4]. While drugs and growth factors can influence these pathways to promote or inhibit neural differentiation (for example, BMP antagonists like Noggin, Notch inhibitors, or retinoic acid), there is no single molecular entity called "Differentiation into neural cell types." This term describes an essential part of brain and nervous system development, regeneration, and disease[1][2][4].
Modulation of signaling pathways involved in neural fate (e.g., Notch, Wnt, BMP, FGF, SHH)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Differentiation into neural cell types.